The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria
Open accessAbstract
After initial successful evaluation of the circumsporozoite-based vaccine RTS,S/SBAS2, developed by SmithKline Beecham Biologicals with the Walter Reed Army Institute of Research, protective efficacy of several regimens against Plasmodium falciparum challenge was determined. A controlled phase 1/2a study evaluated 1 or 2 standard doses of RTS,S/SBAS2 in 2 groups whose members received open-label therapy and 3 immunizations in blinded groups who received standard, one-half, or one-fifth doses. RTS,S/SBAS2 was safe and immunogenic in all groups. Of the 41 vaccinees and 23 control subjects who underwent sporozoite challenge, malaria developed in 7 of 10 who received 1 dose, in 7 of 14 who received 2 doses, in 3 of 6 who received 3 standard doses, in 3 of 7 who received 3 one-half doses, in 3 of 4 who received 3 one-fifth doses, and in 22 of 23 control subjects. Overall protective efficacy of RTS,S/SBAS2 was 41% (95% confidence interval, 22%-56%; P=.0006). This and previous studies have shown that 2 or 3 doses of RTS,S/SBAS2 protect against challenge with P. falciparum sporozoites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Self-citationSAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE
Ripley Ballou, W., Hoffman, S. L., Sherwood, J. A., Hollingdale, M. R., Neva, F. A., Hockmeyer, W. T., Gordon, D. M., Schneider, I., Wirtz, R. A., Young, J. F., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90540-x · Cited by 427
Cerami, C., Frevert, U., Sinnis, P., Takacs, B., Clavijo, P., Santos, M. J., & Nussenzweig, V. (1992) · Cell · doi:10.1016/0092-8674(92)90251-7 · Cited by 356
Nabarro, D. N. (1999) · PubMed · Cited by 311
Saponins as vaccine adjuvants.
Kensil, C. R. (1996) · PubMed · Cited by 296
Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine
Stoute, J. A., Kester, K. E., Krzych, U., Wellde, B. T., Hall, T., White, K., Glenn, G., Ockenhouse, C. F., Garcon, N., Schwenk, R., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515657 · Cited by 236
Self-citationThe "Roll Back Malaria" Campaign
Nabarro, D. N., & Tayler, E. M. (1998) · Science · doi:10.1126/science.280.5372.2067 · Cited by 182
Aidoo, M., Lalvani, A., Allsopp, C. E. M., Plebanski, M., Krausa, P., Browning, M. J., Gotch, F., Robson, K., Hill, A. V. S., Meisner, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90754-8 · Cited by 146
Malaria Transmitted to Humans by Mosquitoes Infected from Cultured Plasmodium falciparum
Chulay, J. D., Schneider, I., Cosgriff, T. M., Hoffman, S. L., Ballou, W. R., Quakyi, I. A., Carter, R., Trosper, J. H., & Hockmeyer, W. T. (1986) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1986.35.66 · Cited by 141
Self-citationWirtz, R. A., Ballou, W. R., Schneider, I., CHEDID, L. A., Gross, M. J., Young, J. F., Hollingdale, M. R., Diggs, C. L., & Hockmeyer, W. T. (1987) · Experimental Parasitology · doi:10.1016/0014-4894(87)90158-5 · Cited by 62
Self-citationHollinger, F. B., Troisi, C., & Pepe, P. E. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.1.156 · Cited by 53
Folena-Wasserman, G., Inacker, R., & Rosenbloom, J. (1987) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)93985-2 · Cited by 24
Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A
Glenn, G. M., Rao, M., Richards, R. L., Matyas, G. R., & Alving, C. R. (1995) · Immunology Letters · doi:10.1016/0165-2478(95)00069-h · Cited by 24
Malaria in 1998: advances in diagnosis, drugs and vaccine development
Heppner, D. G., & Ballou, W. R. (1998) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-199810000-00002 · Cited by 21
Self-citation
Cited by
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Seder, R. A., Chang, L.-J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., Holman, L. A., James, E. R., Billingsley, P. F., Gunasekera, A., et al. (2013) · Science · doi:10.1126/science.1241800 · Cited by 761
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Self-citationMalaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
Bojang, K. A., Milligan, P. J., Pinder, M., Vigneron, L., Alloueche, A., Kester, K. E., Ballou, W. R., Conway, D. J., Reece, W. H., Gothard, P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06957-4 · Cited by 528
Self-citationKester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Self-citation
Metadata
- Authors
- Kester, K. E., McKinney, D. A., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Krzych, U., Delchambre, M., Voss, G., Dowler, M. G., Palensky, J., Wittes, J., Cohen, J., Ballou, W. R., & RTS, S. M. V. E. G.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-15
- Volume
- 183
- Issue
- 4
- Pages
- 640-647
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2155144810
- Cited by
- 271
- References
- 14
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.